AGI-5198
AGI-5198 (IDH-C35) is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0.07 μM.
Product Specifications
CAS Number
1355326-35-0
Product Name Alternative
IDH-C35
UNSPSC
12352005
Hazard Statement
H301
Target
Isocitrate Dehydrogenase (IDH)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AGI-5198.html
Purity
99.93
Solubility
DMF : ≥ 50 mg/mL|DMSO : 20.83 mg/mL (ultrasonic)
Smiles
FC1=CC=CC(N(C(C2=CC=CC=C2C)C(NC3CCCCC3)=O)C(CN4C=CN=C4C)=O)=C1
Molecular Formula
C27H31FN4O2
Molecular Weight
462.56
Precautions
H301
References & Citations
[1]Rohle D, et al. An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. Science. 2013 May 3;340 (6132) :626-30.|[2]Molenaar RJ, et al. Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198. Cancer Res. 2015 Nov 15;75 (22) :4790-802.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IDH1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
40729061 1.0 µg DNA
RPL10 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details NBP2-76651MFV500 0.1 mL
Mouse Monoclonal Maltose Binding Protein Antibody (R29.6) [mFluor Violet 500 SE]
Sign In for Pricing
View Details